Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
Steroid-induced osteoporosis is a common side effect of long-term treatment with glucocorticoid (GC) drugs. GCs have multiple systemic effects that may influence bone metabolism but also directly affect osteoblasts by decreasing proliferation. This may be beneficial at low concentrations, enhancing...
Huvudupphovsmän: | Horsch, K, De Wet, H, Schuurmans, M, Allie-Reid, F, Cato, A, Cunningham, J, Burrin, J, Hough, F, Hulley, P |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2007
|
Liknande verk
Liknande verk
-
Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines.
av: Engelbrecht, Y, et al.
Publicerad: (2003) -
Rapid inhibitory effects of glucocorticoids on ERK activity and osteoblast proliferation occur via transcriptional upregulation of MKP-1
av: Horsch, K, et al.
Publicerad: (2004) -
Rapid inhibitory effects of glucocorticoids on ERK activity and osteoblast proliferation occur via transcriptional upregulation of MKP-1
av: Horsch, K, et al.
Publicerad: (2004) -
Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases.
av: Hulley, P, et al.
Publicerad: (1998) -
The tyrosine phosphatase inhibitor vanadate protects osteoblasts from growth inhibition by glucocorticoids.
av: Hulley, P, et al.
Publicerad: (1999)